Blood study provides hope for stem cell therapy
CRM researchers have pinpointed a key enzyme vital for the production of all blood cells which could lead to improved stem cell therapy.
New Cancer Research Tools
CRM scientists have been able to make precise genetic changes to mouse and human neuronal stem cells for the first time.
New clues to cause of bile duct cancer
Scientists at the CRM have identified a molecule that drives the development of bile duct cancer. The research in mice and human cells sheds new light on what triggers the disease and how the illness progresses.
Cell Reports study
Dr Katrin Ottersbach: "Our findings reveal the first changes that take place in blood development caused by the MLL-AF4 mutation during a pre-cancerous state."